| Name | Ethyl 4-(4-chlorophenyl)-1,3-thiazole-2-carboxylate |
|---|---|
| Synonyms |
ETHYL 4-(4-CHLOROPHENYL)THIAZOLE-2-CARBOXYLATE
ethyl-2-[4-(4-chlorophenyl)]thiazolylcarboxylate 4-(4-Chloro-phenyl)-thiazole-2-carboxylic acid ethyl ester ethylchlorophenylthiazolecarboxylate |
| Molecular Formula | C12H10ClNO2S |
|---|---|
| Molecular Weight | 267.73100 |
| Exact Mass | 267.01200 |
| PSA | 67.43000 |
| LogP | 3.64020 |
| HS Code | 2934100090 |
|---|
|
~54%
75680-91-0 |
| Literature: Apogee Biotechnology Corporation Patent: US2007/32531 A1, 2007 ; Location in patent: Page/Page column 41 ; US 20070032531 A1 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |